Basic Information
RNALocate ID: | RLID:01002000 |
RNA Symbol: | hsa-miR-296-5p |
Localization: | Mitochondrion |
RNA Information
RNA Name: | hsa-miR-296-5p |
RNA ID: | miRBase:MIMAT0000690 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 21637849 |
Tissue/Cell Line: | Skeletal muscle myoblasts |
Method: | ISH|qRT-PCR |
Description: | List of microRNA significantly detected in the mitochondrial mRNA at three increasing mtRNA inputs (1, 5 and 35 uL). Table S3 List of microRNA significantly detected (Cp<35) in the mitochondrial mRNA at the two highest mtRNA inputs (5 and 35 uL). Data are collected from Table 4 and S3. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002001 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11002382 | Exosome | Serum | 18589210 |
RLID:11002383 | Exosome | Renal cancer cells | 21670082 |
RLID:11002384 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID-D:11000402 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001190 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-296-5p | Oral squamous cell carcinoma | MNDR-E-MI-34307 |
MNDR | hsa-miR-296-5p | B cell lymphoma of malt type | MNDR-E-MI-34308 |
MNDR | hsa-miR-296-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-34309 |
MNDR | hsa-miR-296-5p | Lymphoma | MNDR-E-MI-34310 |
MNDR | hsa-miR-296-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-34311 |
MNDR | hsa-miR-296-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-34312 |
MNDR | hsa-miR-296-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-34313 |
MNDR | hsa-miR-296-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-34314 |
MNDR | hsa-miR-296-5p | Breast cancer luminal | MNDR-E-MI-34315 |
MNDR | hsa-miR-296-5p | Niemann-pick disease type c | MNDR-E-MI-34316 |
MNDR | hsa-miR-296-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-34317 |
MNDR | hsa-miR-296-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-34318 |
MNDR | hsa-miR-296-5p | Dermatomyositis | MNDR-E-MI-34319 |
MNDR | hsa-miR-296-5p | Prostate cancer | MNDR-E-MI-34320 |
MNDR | hsa-miR-296-5p | Gastric cancer | MNDR-E-MI-34321 |
MNDR | hsa-mir-296-5p | Gastric cancer | MNDR-E-MI-34322 |
MNDR | hsa-miR-296-5p | Alzheimer disease | MNDR-E-MI-34323 |
MNDR | hsa-miR-296-5p | Essential hypertension | MNDR-E-MI-34324 |
MNDR | hsa-miR-296-5p | Intracranial aneurysm | MNDR-E-MI-34325 |
MNDR | hsa-miR-296-5p | Dysautonomia familial | MNDR-E-MI-34326 |
MNDR | hsa-miR-296-5p | Head and neck cancer | MNDR-E-MI-34327 |
MNDR | hsa-miR-296-5p | Primary biliary cirrhosis | MNDR-E-MI-34328 |
MNDR | hsa-miR-296-5p | Leukemia | MNDR-E-MI-34329 |
MNDR | hsa-miR-296-5p | Cardiovascular disease | MNDR-E-MI-34330 |
MNDR | hsa-miR-296-5p | Lung cancer | MNDR-E-MI-34331 |
MNDR | hsa-miR-296-5p | Parkinson disease | MNDR-E-MI-34332 |
MNDR | hsa-miR-296-5p | Niemann-pick disease | MNDR-E-MI-34333 |
MNDR | hsa-miR-296-5p | Basal-like breast cancer | MNDR-E-MI-34334 |
MNDR | hsa-miR-296-5p | Pancreatic cancer | MNDR-E-MI-34335 |
MNDR | hsa-miR-296-5p | Melanoma | MNDR-E-MI-34336 |
MNDR | hsa-miR-296-5p | Rectum adenocarcinoma | MNDR-E-MI-34337 |
MNDR | hsa-miR-296-5p | Nephroblastoma | MNDR-E-MI-34338 |
MNDR | hsa-miR-296-5p | Colon cancer | MNDR-E-MI-34339 |
MNDR | hsa-miR-296-5p | Colon adenocarcinoma | MNDR-E-MI-34340 |
MNDR | hsa-miR-296-5p | Familial ovarian cancer | MNDR-E-MI-34341 |
MNDR | hsa-miR-296-5p | Prostate adenocarcinoma | MNDR-E-MI-34342 |
MNDR | hsa-miR-296-5p | Carcinoma ductal breast | MNDR-E-MI-34343 |
MNDR | hsa-miR-296-5p | Invasive ductal carcinoma | MNDR-E-MI-34344 |
MNDR | hsa-miR-296-5p | Glioblastoma | MNDR-E-MI-34345 |
MNDR | hsa-miR-296-5p | Astrocytoma | MNDR-E-MI-34346 |
MNDR | hsa-miR-296-5p | Glioma | MNDR-E-MI-34347 |
MNDR | hsa-miR-296-5p | Neurilemmoma | MNDR-E-MI-34348 |
MNDR | hsa-miR-296-5p | Central nervous system lymphoma | MNDR-E-MI-34349 |
MNDR | hsa-miR-296-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-34350 |
MNDR | hsa-miR-296-5p | Osteosarcoma | MNDR-E-MI-34351 |
MNDR | hsa-miR-296-5p | Inclusion body myositis | MNDR-E-MI-34352 |
MNDR | hsa-miR-296-5p | Breast carcinoma | MNDR-E-MI-34353 |
MNDR | hsa-miR-296-5p | Liver cancer | MNDR-E-MI-34354 |
MNDR | hsa-miR-296-5p | Uterine cancer | MNDR-E-MI-34355 |
MNDR | hsa-miR-296-5p | Cervical squamous cell carcinoma | MNDR-E-MI-34356 |
MNDR | hsa-miR-296-5p | Lung squamous cell carcinoma | MNDR-E-MI-34357 |
MNDR | hsa-miR-296-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-34358 |
MNDR | hsa-miR-296-5p | Lung adenocarcinoma | MNDR-E-MI-34359 |
MNDR | hsa-miR-296-5p | Adrenocortical cancer | MNDR-E-MI-34360 |
MNDR | hsa-miR-296-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-34361 |
MNDR | hsa-miR-296-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-34362 |
MNDR | hsa-miR-296-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-34363 |
MNDR | hsa-miR-296-5p | Renal clear cell carcinoma | MNDR-E-MI-34364 |
MNDR | hsa-miR-296-5p | Biliary tract cancer | MNDR-E-MI-34365 |
MNDR | hsa-miR-296-5p | Cholangiocarcinoma | MNDR-E-MI-34366 |
MNDR | hsa-miR-296-5p | Esophageal cancer | MNDR-E-MI-34367 |
MNDR | hsa-miR-296-5p | Synovial sarcoma | MNDR-E-MI-34368 |
MNDR | hsa-miR-296-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-34369 |
MNDR | hsa-miR-296-5p | T acute lymphoblastic leukemia | MNDR-E-MI-34370 |
MNDR | hsa-miR-296-5p | Acute t cell leukemia | MNDR-E-MI-34371 |
MNDR | hsa-miR-296-5p | Adenoma | MNDR-E-MI-34372 |
MNDR | hsa-miR-296-5p | Breast invasive carcinoma | MNDR-E-MI-34373 |
MNDR | hsa-miR-296-5p | Hepatocellular carcinoma | MNDR-E-MI-34374 |
MNDR | hsa-miR-296-5p | Familiar ovarian carcinoma | MNDR-E-MI-34375 |
MNDR | hsa-miR-296-5p | B-cell lymphoma | MNDR-E-MI-34376 |
MNDR | hsa-miR-296-5p | Neuroblastoma | MNDR-E-MI-34377 |
MNDR | hsa-miR-296-5p | Acute myelogenous leukemia | MNDR-E-MI-34378 |
MNDR | hsa-miR-296-5p | Colorectal cancer | MNDR-E-MI-34379 |
MNDR | hsa-miR-296-5p | Nasopharynx carcinoma | MNDR-E-MI-34380 |
MNDR | hsa-miR-296-5p | Multiple myeloma | MNDR-E-MI-34381 |
MNDR | hsa-miR-296-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-34382 |
MNDR | hsa-miR-296-5p | Ependymoma | MNDR-E-MI-34383 |
MNDR | hsa-miR-296-5p | Nasopharyngeal cancer | MNDR-E-MI-34384 |
MNDR | hsa-miR-296-5p | Pseudorabies | MNDR-E-MI-34385 |
MNDR | hsa-miR-296-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-34386 |
MNDR | hsa-miR-296-5p | Tubulovillous adenoma | MNDR-E-MI-34387 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BBC3 | Homo sapiens | RR00212856 |
TOP